Of the tracked stories, 2 of 2 also mention Wesper, the most common co-covered peer. Each story carries 3 original sources on average, compared with 4 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 5.9.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about CPAP.com
Of the tracked stories, 2 of 2 also mention Wesper, the most common co-covered peer. Each story carries 3 original sources on average, compared with 4 for the broader beat in this window. At 5, the average consequence score sits below the same-window beat average of 5.9. Coverage clusters in medical-devices, which accounts for 1 of those 2, with the remainder spread across 1 other category. CPAP.com appears in 2 tracked Healthcare stories published from March 13, 2026 through March 16, 2026.
Stories tracked
2
Sources per story
3
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 77 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering CPAP.com. Shared-story counts are live from our verified record — not editorial picks.
CPAP.com has launched a promotional initiative for the Wesper At Home Sleep Test to coincide with Sleep Awareness Month, aiming to bridge the diagnostic gap for sleep apnea. The clinical-grade kit combines wearable sensors with physician-led telehealth evaluations to provide a streamlined path from diagnosis to treatment.
CPAP.com has launched a promotional campaign for its At Home Sleep Test featuring the Wesper device to coincide with Sleep Awareness Month. The clinical-grade kit aims to address the global underdiagnosis of sleep apnea by providing lab-quality insights and physician-led prescriptions from a home setting.